| THEA Pharma S.A. - Fixaprost, collyre en récipient unidose | | 67295 | | 01 | | Fixaprost | | collyre en récipient unidose | | S01ED51 | | Timolol, Combinations | | 17.04.2020 | | |
| | Composition | | latanoprostum 50 µg, timololum 5 mg ut timololi maleas, macrogolglyceroli hydroxystearas 50 mg, sorbitolum, macrogolum 4000, carbomerum, dinatrii edetas, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | collyre en monodoses | | | | | | | | Active Agent | Dose |
|---|
| Latanoprost | 50 µg/ml | | Timolol | 5 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Latanoprost | 50 mcg | | Timolol | 5 mg |
| | | | Inactive agents | Dose |
|---|
| Carbomer | | | Dinatrii Edetas | | | Macrogolglyceroli Hydroxystearas | 50 mg/ml | | Macrogol | 4000 | | Sodium Hydroxide | | | Sorbitol | |
| |
| |
|
